Drug intelligence / Profile preview

caffeine + warfarin + omeprazole + metoprolol + midazolam

Development stage
Unknown
Lead developer
Wisconsin Alumni Research Foundation
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a **combination of five drugs**: caffeine, warfarin, omeprazole, metoprolol, and midazolam. Each drug has a distinct mechanism of action: - **Caffeine** is a central nervous system stimulant that antagonizes adenosine receptors, increasing alertness. - **Warfarin** is a vitamin K antagonist anticoagulant that inhibits vitamin K epoxide reductase to prevent clotting. - **Omeprazole** is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting the H+/K+-ATPase in gastric parietal cells. - **Metoprolol** is a selective beta-1 adrenergic receptor antagonist used primarily to lower blood pressure and treat heart conditions. - **Midazolam** is a benzodiazepine that acts as a positive allosteric modulator of the GABA-A receptor, producing sedative and anxiolytic effects. This combination is not marketed as a single product and is primarily encountered in research contexts as a probe cocktail to study drug metabolism and pharmacokinetic interactions involving the cytochrome P450 system. Clinical use of all five drugs together is highly unusual and may present safety concerns due to interactions.

02

Targets

ADORA2A (Adenosine A₂A Receptor)VKORC1 (Vitamin K epoxide reductase complex subunit 1)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on caffeine + warfarin + omeprazole + metoprolol + midazolam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on caffeine + warfarin + omeprazole + metoprolol + midazolam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call